Leflunomide
Showing 26 - 50 of 172
Rheumatoid Arthritis Trial in Omaha (Methotrexate, Abatacept, Adalimumab)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
- +15 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Oct 28, 2021
Hepatotoxicity in Rheumatoid Arthritis Through Pharmacokinetic
Completed
- Rheumatoid Arthritis
- Leflunomide 20Mg Tab
-
Assiut, EgyptAssiut University Hospital
Sep 6, 2020
The Registry Study of Takayasu Arteritis in East China
Recruiting
- Takayasu Arteritis
- +4 more
- Tocilizumab
- Leflunomide
-
Shanghai, Shanghai, ChinaDepartment of Rheumatology in Zhongshan hospital, Fudan Universi
Aug 7, 2021
Arthritis, Rheumatoid Trial in Belgium (Etanercept 50 MG/ML, Leflunomide 10 milligram (MG))
Completed
- Arthritis, Rheumatoid
- Etanercept 50 MG/ML
- Leflunomide 10 milligram (MG)
-
Bonheiden, Antwerpen, Belgium
- +18 more
Jul 4, 2022
Glomerulonephritis, IGA, Renal Insufficiency, Chronic Trial in Shenzhen (Leflunomide 20 mg+prednisone 0.5mg/kg/d)
Unknown status
- Glomerulonephritis, IGA
- Renal Insufficiency, Chronic
- Leflunomide 20 mg+prednisone 0.5mg/kg/d
-
Shenzhen, Guangdong, ChinaXu Yi
Feb 14, 2020
Kidney Transplant Infection, BK Virus Infection Trial in Bangkok (Everolimus, reduced dose tacrolimus)
Recruiting
- Kidney Transplant Infection
- BK Virus Infection
- Everolimus
- reduced dose tacrolimus
-
Bangkok, ThailandKing Chulalongkorn Memorial Hospital
Nov 10, 2022
(CHOIR)
Recruiting
- Chronic Nonbacterial Osteomyelitis
- Chronic Recurrent Multifocal Osteomyelitis
- Methotrexate
- +9 more
-
Seattle, WashingtonSeattle Children's Hospital
Jan 25, 2021
Smoldering Plasma Cell Myeloma Trial in Duarte (Leflunomide, Quality-of-Life Assessment, Questionnaire Administration)
Withdrawn
- Smoldering Plasma Cell Myeloma
- Leflunomide
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 12, 2019
Rheumatoid Arthritis Trial in Chicago (Lab Work, Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of
Completed
- Rheumatoid Arthritis
- Lab Work
- +11 more
-
Chicago, IllinoisOutpatient Care Center
Jul 13, 2020
Rheumatoid Arthritis Trial in Cairo (Cilostazol 100 MG, conventional synthetic antirheumatic drugs)
Recruiting
- Rheumatoid Arthritis
- Cilostazol 100 MG
- conventional synthetic antirheumatic drugs
-
Cairo, EgyptAl-Zahraa Hospital
Dec 26, 2022
Henoch-Schoenlein Purpura Nephritis Trial in Nanjing (Prednisone, Cyclophosphamide(CTX), Mycophenolate mofetil(MMF))
Unknown status
- Henoch-Schoenlein Purpura Nephritis
- Prednisone
- +5 more
-
Nanjing, Jiangsu, ChinaNanjing Children's Hospital
Feb 25, 2020
T and B Cell Repertoire Changes in Response to Orencia® in
Recruiting
- Rheumatoid Arthritis
-
New York, New YorkHospital for Special Surgery
Mar 13, 2023
Polymyalgia Rheumatica Trial in Almelo, Groningen (Leflunomide 20 mg, Prednisolone)
Unknown status
- Polymyalgia Rheumatica
- Leflunomide 20 mg
- Prednisolone
-
Almelo, Netherlands
- +1 more
May 30, 2019
Rheumatoid Arthritis Trial in Pondicherry (Methotrexate, Leflunomide, Hydroxychloroquine)
Completed
- Rheumatoid Arthritis
- Methotrexate
- +4 more
-
Pondicherry, Pondicherry UT, IndiaJawaharlal Institute of Postgraduate Medical Education & Researc
Sep 28, 2019
Immunoglobulin G4 Related Sclerosing Disease Trial in Beijing (Prednisone, Leflunomide)
Completed
- Immunoglobulin G4 Related Sclerosing Disease
- Prednisone
- Leflunomide
-
Beijing, ChinaChinese PLA General Hospital
Mar 4, 2019
Mechanistic Studies of Teriflunomide in RRMS
Active, not recruiting
- Relapsing Remitting Multiple Sclerosis
-
Ann Arbor, MichiganUniversity of Michigan
Jul 27, 2022
Monitoring of Inflammatory Conditions
Recruiting
- Inflammatory Disease
- +8 more
- Questionnaire
- Semi-structured interview
-
Nottingham, Nottinghamshire, United KingdomUniversity of Nottingham
Jul 11, 2022
Connective Tissue Diseases, Thrombocytopenia Trial in China (Telitacicept, Placebo)
Not yet recruiting
- Connective Tissue Diseases
- Thrombocytopenia
- Telitacicept
- Placebo
-
Hefei, Anhui, China
- +21 more
Aug 18, 2023
Power Doppler in Hand Joints of Early RA Patients
Completed
- Early Rheumatoid Arthritis
- Drug protocol
- (no location specified)
Feb 15, 2021
Rheumatoid Arthritis Trial in Mansoura (Montelukast, Placebo, Conventional DMARDs)
Not yet recruiting
- Rheumatoid Arthritis
- Montelukast
- +2 more
-
Mansoura, EgyptMansoura University
Jul 1, 2022
Rheumatoid Arthritis Trial in Montpellier (Abatacept (M3-M12), TNF Inhibitor (M3-M12), TNF Inhibitor (M0-M3))
Not yet recruiting
- Rheumatoid Arthritis
- Abatacept (M3-M12)
- +2 more
-
Montpellier, FranceCentre Hospitalier Universitaire de Montpellier
Jun 16, 2022
Inflammatory Bowel Disease Related Joint Manifestations
Not yet recruiting
- IBD
- Joint Diseases
- (no location specified)
Jan 12, 2023
Autoimmune Disease Trial in Beijing (Prednisone, Prednisone and Leflunomide)
Unknown status
- Autoimmune Disease
- Prednisone
- Prednisone and Leflunomide
-
Beijing, Beijing, ChinaYunyun Fei
Oct 21, 2018
COVID-19 Trial in Australia (diphtheria and tetanus toxoids (adsorbed) vaccine, COVID-19 vaccine)
Not yet recruiting
- COVID-19
- diphtheria and tetanus toxoids (adsorbed) vaccine
- COVID-19 vaccine
-
Blacktown, New South Wales, Australia
- +4 more
Nov 20, 2022